Revive Therapeutics Ltd
Change company Symbol lookup
Select an option...
RVVTF Revive Therapeutics Ltd
ALMMF Aluminum Corp of China Ltd
FUN Cedar Fair LP
BAC Bank of America Corp
XLF Financial Select Sector SPDR® Fund
FRAN Francesca's Holdings Corp
ED Consolidated Edison Inc
BIIB Biogen Inc
CNF CNFinance Holdings Ltd
LVS Las Vegas Sands Corp
Go

Health Care : Pharmaceuticals | Small Cap Blend
Based in Canada
Company profile

Revive Therapeutics Ltd (Revive) is engaged in commercializing treatments for rare diseases, such as Cystinuria, Wilson's disease and Rett syndrome. The Company has completed a Phase II-A study for acute gout flares in the United States. The Company's business model focuses on finding new uses of old drugs with the objective of finding a partner or partners to bring the new use drug to the marketplace. The Company is focused on the development of Bucillamine for the treatment of cystinuria (REV-004). The Company's product pipeline includes Bucillamine for the treatment of acute gout flares (REV-002), Tianeptine for treatment of Rett Syndrome (REV-003), and Bucillamine for treatment of Wilson's disease (REV-005). The Company is focused on the development and commercialization of drugs for underserved medical needs. The Company is also evaluating additional drug repurposing candidates and formulations.

Closing Price
$0.23
Day's Change
-0.065 (-22.03%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.30
Day's Low
0.2003
Volume
(Heavy Day)
Volume:
4,635,097

10-day average volume:
2,985,376
4,635,097
  • Prev Close
    0.295
  • Today's Open
    0.285
  • Day's Range
    0.2003-0.30
  • Avg Vol (10-day)
    3.0M
  • Last (time)
    3:59p ET 07/02/20
  • Last (size)
    500
  • 52-Wk Range
    0.0173 - 0.50
    LowHigh
  • (12/16/19 - 07/01/20)
    1,229.48%
  • 223.9%
  • Market Cap
    37.1M
  • Shares Outstanding
    163.9M
  • -0.03
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -1.0
  • --
  • --

Latest News

June 30, 2020
3:45 pm ET
Globe Newswire
June 18, 2020
9:16 pm ET
Newsfile
June 12, 2020
8:09 am ET
Globe Newswire
June 09, 2020
12:06 pm ET
Globe Newswire
June 03, 2020
11:09 am ET
Globe Newswire
May 13, 2020
9:37 am ET
Globe Newswire
April 29, 2020
8:24 am ET
Globe Newswire
April 23, 2020
8:38 am ET
Globe Newswire
April 21, 2020
11:22 am ET
Globe Newswire
April 17, 2020
8:16 am ET
Globe Newswire
April 15, 2020
9:00 am ET
Globe Newswire
April 08, 2020
9:18 am ET
Globe Newswire
Go to all current & historical news

Events

There are no calendar events for RVVTF.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.